Injuries before and after diagnosis of cancer: nationwide register based study + comment/s

i·at·ro·gen·ic īˌatrəˈjenik/ adjective adjective: iatrogenic

1. of or relating to illness caused by medical examination or treatment.

 We used the Swedish revision of ICD-7 (international classification of diseases, seventh revision) to classify cancers as prostate cancer (n=123 837), breast cancer (n=101 458; women only), colorectal cancer (n=84 527), non-melanoma skin cancer (n=33 409), lymphatic or hematopoietic cancers (n=52 266), lung cancer (n=49 491), cancers of the central nervous system (n=21 199), cancers with an expectedly short survival
(n=34 627; “severe cancers” including cancers in the oesophagus, liver, and pancreas), and other cancers (n=220 087).

open access

 Based on this register, we included 740 114 unique patients with a first cancer diagnosed during 1991-2009.

 
Responses 

2016 Canadian Cancer Statistics

full version (142 pages)

lifetime probability of developing ovarian cancer: 1 in 71
estimate new cases (2016):  2,800
estimated deaths(2016):      1,750

New York: Dear America, you’re already great. Love Canada: Social media campaign to boost U.S. spirits takes off

Blogger's Note: having a bad day? Read this:

Dear America, you’re already great. Love Canada: Social media campaign to boost U.S. spirits takes off 

 The campaign has spawned headlines on the websites of prominent news outlets based in the U.S., Britain and Canada.

NEW YORK — A social media campaign started by a Toronto-based creative agency has gained international attention for its effort to boost American spirits as the U.S. goes through a fractious presidential election.
Using the hashtag #tellamericaitsgreat, Canadians have swamped Twitter with compliments about American music, culture, technology and even tailgating. The outpouring of love triggered a reply — #TellCanadaThanks.
It’s all an effort started by the Toronto-based ad agency The Garden Collective, which chose its hashtag as a play on Republican presidential candidate Donald Trump’s campaign slogan, “Make America great again.” The firm’s video launching the social media push has gotten over 752,000 YouTube views and the hashtag has been trending on Twitter for several days. Many Canadians have made their own mini-videos, too.
Dic Dickerson, managing director of the firm, called it a pet project they devised for no other reason than to just spread love. “We put it out there and I don’t think any of us expected to get as much traction as it did but we’re really, really excited by all the positivity,” he said. “A lot of people are talking, which is exactly what we wanted.”....

When Clinical Care Depends on the Answer: The Challenges of Assessing Germline Cancer Gene Variants

Editorial - open access

 

Detection of Mismatch Repair Deficiency in Colorectal Cancers: Is It Really Time to Eliminate Immunohistochemistry?

Detection of Mismatch Repair Deficiency in Colorectal Cancers: Is It Really Time to Eliminate Immunohistochemistry?

Related Articles

• CORRESPONDENCE: Reply to G. Le Flahec et al
  

  • Joanne Ngeow and
  • Charis Eng

  JCO JCO699405; published online on October 17, 2016;
  • [Full Text]
  • [PDF]
• CORRESPONDENCE: Reply to G. Le Flahec et al
  

  • Zsofia K. Stadler and
  • Leonard B. Salt

  •  Thus, for patients undergoing either an IHC or NGS analysis of their tumors, decisions on charges, as opposed to costs, by either laboratories or payers may well dictate which manner of testing for MMR status is more cost effective. Duplication of effort, however, is always more costly, and for those patients whose tumors will as a matter of course undergo assessment via an NGS panel for RAS or BRAF or for other reasons, the additional performance of MMR IHC is likely to constitute an unnecessary expense that can and should be avoided.

  JCO JCO699413; published online on October 17, 2016;
  
  

  • [Full Text]
  • [PDF]

REFERENCES

1. 1.↵
   1. Stadler ZK,
   2. Battaglin F,
   3. Middha S,
   4. et al.

   (2016) Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels. J Clin Oncol 34:2141–2147.

   Abstract/FREE Full Text
2. 2.↵
   1. Le DT,
   2. Uram JN,
   3. Wang H,
   4. et al.

   (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520.

   CrossRefMedlineGoogle Scholar
3. 3.↵
   1. National Comprehensive Cancer Network

   , NCCN clinical practice guidelines in oncology (NCCN guidelines): Genetic/familial high-risk assessment—Colorectal. http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf.
4. 4.↵
   1. Stoffel EM,
   2. Mangu PB,
   3. Limburg PJ

   (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk–colorectal cancer: European Society for Medical Oncology clinical practice guidelines. J Oncol Pract 11:e437–e441.

   FREE Full Text
5. 5.↵
   1. Uguen A,
   2. Guéguen P,
   3. Legoupil D,
   4. et al.

   (2015) Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice. Hum Pathol 46:1582–1591.

   CrossRefMedlineGoogle Scholar
6. 6.↵
   1. Nolan S,
   2. Arnason T,
   3. Drucker A,
   4. et al.

   (2014) The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability. Appl Immunohistochem Mol Morphol 22:e8–e13.

   CrossRefMedlineGoogle Scholar
7. 7.↵
   1. Turchini J,
   2. Andrici J,
   3. Sioson L,
   4. et al.

   NRASQ61R mutation-specific immunohistochemistry is highly specific for either NRASQ61R or KRASQ61R mutation in colorectal carcinoma. Appl Immunohistochem Mol Morphol, [epub ahead of print on February 9, 2016].

   Google Scholar
8. 8.↵
   1. Colling R,
   2. Wang LM,
   3. Soilleux E

   (2016) Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: A diagnostic test accuracy study. J Clin Pathol 69:398–402.

   Abstract/FREE Full Text